Articles

The audits are the main regulatory tool for many industries especially the medical device and pharmaceutical sector. The audits, whether they are internal, vendor-based, or regulatory, should be done by organizations to show that they comply with the strict quality standards of cGMP, QMS, and CAPA. The article exposes the ins and outs of audits, regulatory inspections, and compliance requirements, with a special emphasis on FDA inspections and the QSIT (Quality System Inspection Technique) approach.
Introduction to Audits In the fields of pharmaceuticals and medical devices where regulation is imposed, compliance with the quality standards set by the authorities is vital for the protection of the products from dangerous effects and ensuring therapeutic efficiency. Audits form an integral pa…

In an industry where every healthcare provider (HCP) interaction carries significant weight, ACTO’s CxZone has been recognized for its approach to pharmaceutical field training. In the 2025 Pharmaceutical Technology Excellence Awards, ACTO won awards in both the Innovation (AI Roleplay) and Product Launches (Field Simulation) categories for CxZone. ACTO’s approach to bridging the gap between strategy and execution, along with its integration into pharma field professionals’ workflows, has drawn attention within the life sciences sector.
ACTO’s CxZone won the Innovation award in the AI Roleplay category for its targeted use of AI roleplay to address persistent challenges in pharmaceutical field engagement. One of the most significant hurdles for pharmaceutical companies is ensuring that t…

“An ounce of prevention is worth a pound of cure.” Benjamin Franklin’s maxim may predate modern medicine, yet its logic underpins the realities of pharmaceutical manufacturing today. When a single interruption can destabilise controlled systems, jeopardise batch integrity or delay time-critical medicines, preventing disruption is as important as resolving it. Here, Andrew Keith, division director of load bank manufacturer Power Prove, examines how robust backup power testing helps reduce unplanned downtime in pharmaceutical operations.
~ How load bank testing prevents downtime in pharmaceutical manufacturing ~ “An ounce of prevention is worth a pound of cure.” Benjamin Franklin’s maxim may predate modern medicine, yet its logic underpins the realities of pharmaceutical manufacturing today.…

Pharmacovigilance (PV) teams are facing sustained pressure from rising ICSR volumes, expanding intake channels (partners, call centres, patient programs, digital touchpoints), tighter regulatory timelines, and higher expectations for inspection readiness. Many organisations, however, still run PV operations through fragmented mailboxes, manual triage queues, and spreadsheet-heavy reconciliation. The most effective modernisation approach is not “adding AI everywhere,” but redesigning PV workflows so repeatable work is orchestrated consistently, exceptions are handled early, and medical judgement remains explicit and auditable.
Modernizing Pharmacovigilance Operations: Practical Automation Patterns for Case Intake, Triage, and Signal Workflows Pharmacovigilance (PV) teams are facing a sustain…

The global biomarkers market is at the forefront of healthcare’s shift toward precision, data-driven medicine. Valued at USD 85.9 billion in 2025 and projected to reach USD 244.8 billion by 2034 at a CAGR of 12.3%.
The landscape of modern healthcare is undergoing a seismic shift, moving away from "one-size-fits-all" treatments toward a highly tailored, data-driven approach. At the heart of this transformation is the global biomarkers market. Valued at USD 85.9 billion in 2025, the sector is projected to surge to an astonishing USD 244.8 billion by 2034. This trajectory, representing a compound annual growth rate (CAGR) of 12.3%, underscores a fundamental change in how we diagnose, monitor, and treat chronic diseases. The Catalysts of Growth: Why Now? The explosive expansion of the biomarker…

The use of AI in pharmaceutical development is becoming widespread, but the rulebook is still being written.
The use of AI in pharmaceutical development is becoming widespread, but the rulebook is still being written. McKinsey reports that 71% of businesses across various industries now use generative AI, with life sciences sitting among the fastest adopters. However, only 53% actively mitigate AI risks. This gap now leads to unease, as pharmaceutical companies deploy autonomous systems across R&D and manufacturing while simultaneously building their governance frameworks. The conversation has moved on from whether AI belongs in drug discovery or production lines. The big question is how those businesses secure innovation without restricting the impact that makes AI so valuable. Operati…

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred. The biological processes leave measurable traces in the blood, but only for a limited period. The discovery thus reveals a window of opportunity that could be crucial for future treatment, but also for early diagnosis via blood tests, which could begin to be tested in healthcare within five years.
Parkinson’s is an endemic disease with over 10 million people affected globally. As the world’s population grows older, this number is expected to more than double by 2050. At present, there is neither an effective cure nor an established screening method for detecting this chronic neurological d…

Explore the top EDC platforms for clinical trials in 2026. Features, strengths, limitations, and how to choose the right platform for your study.
Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams running modern trials. In 2026, clinical trial software solutions have become increasingly sophisticated, ranging from enterprise suites to lean, budget-friendly tools. These clinical trial data capture software systems replace legacy tools with secure, centralized, and modern systems, ensuring 21 CFR Part 11 audit trails, encryption, and compliance with ICH-GCP guidelines. EDC systems are central to modern clinical trials, enhancing data accuracy while enabling real-time monitoring, faster database locks, and streamlined wor…

Anti-aging and longevity are expanding beyond beauty into an industry driven by biomarkers like blood sugar, inflammation, sleep, muscle, and biological age. The key question is whether longevity is healthcare or lifestyle, shaping regulation, evidence, pricing, and consumers. Healthcare focuses on measurable interventions to reduce disease risk, while lifestyle emphasizes daily habits supported by nutraceuticals, wearables, and digital coaching. Ultimately, the market grows fastest in the middle ground, where trust and sustainable routines matter most.
The desire to stay young is almost instinctive. Yet in recent years, that desire has evolved beyond simple beauty or wellness, transforming into an entire industry known as longevity. In the past, youthful appearance was often associated wit…

Clinical trial sites deal with many small challenges during daily work managing patient visits, paperwork and timelines can be stressful at times teams also face issues like staff shortages and sudden protocol changes; this article explains the common problems trial sites face and how they affect day to day operations.
When we think of a clinical trial we often imagine the global breakthroughs the headlines announcing a new cure or a revolutionary vaccine however the true work happens in the trenches at the clinical trial sites where research becomes real life care. For those beginning their journey with a clinical research course in India the curriculum often highlights the ideal protocol but as any seasoned professional will tell you the day to day reality at a research site is a delicate…

Hello, I am Gautami Gangadiya, an SEO executive at BotPhonic, and I am passionate about driving digital growth by optimizing presence with strategic SEO initiatives. Let's elevate your brand together!
Introduction The rapid growth of technology-driven customer service makes AI Call Centres among the essentials of modern business today. With the aid of a virtual AI Call Assistant, an organization can do almost all tasks of AI Phone Call concerning customer service and essentially high-quality. An application in a virtual AI Receptionist helps in reducing costs, speeding processes, and allowing personnel to attend queries only an actual human figure can answer. In other words, intelligent systems integrated with automation revolutionizes how organizations go about achieving that cost-effec…

In high-volume manufacturing, the margin for error is non-existent. When producing components for medical disposable products, industrial machinery or performance apparel.  The physical properties of a polymer must remain identical from the first pound to the ten-thousandth. Any fluctuation in tensile strength or material performance can lead to product failure or costly production downtime.
Achieving this level of reliability requires more than just heavy machinery; it demands a scientific approach to polymer chemistry and a disciplined manufacturing process. The Foundation of Batch Consistency Consistency begins with the precision of the formulation. Even slight variations in the quality of raw materials or the sequence of addition can alter the final compound’s behaviour. Fulflex offers…

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development.
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. Meticulous records of clonality, phenotypic stability, and quality control do more than simply satisfy regulators. They set an established groundwork for reproducible yield and effective tech transfer from early-stage deve…

By Vibhor Gupta, founder & CEO of Pangaea Data - As 2026 begins, the conversation around AI in healthcare feels markedly different from this time last year. Not because the technology itself has changed, but because expectations have. Across health systems, life sciences and R&D departments, there’s been a profound shift away from experimentation for its own sake towards accountable, transparent and reliable AI that demonstrates ROI within real care pathways, under real-world conditions.
As 2026 begins, the conversation around AI in healthcare feels markedly different from this time last year. Not because the technology itself has changed, but because expectations have. Across health systems, life sciences and R&D departments, there’s been a profound shift away from experimentation…

Aston University and Midlands-based company PFE Medical are teaming up to create biodegradable gloves made from food waste for use in the NHS.
Knowledge Transfer Partnership between Aston University and PFE Medical to develop a biodegradable clinical glove from food waste The gloves will provide a low-cost, convenient and sustainable alternative to the 1.4bn disposable gloves used in the NHS each year The innovation will reduce clinical waste and costs and help the NHS reach its net zero goals. Aston University and Midlands-based company PFE Medical are teaming up to create biodegradable gloves made from food waste for use in the NHS. They will offer a low-cost, convenient alternative to disposable gloves without compromising patient safety. More than 1.4bn disposable gloves are used by t…

Technology is changing how clinical trials are planned and carried out today simple digital tools help researchers collect data faster and reduce mistakes. Online systems also make it easier to track patient safety and study progress because of this trials can run more smoothly and reach results in less time while keeping patient care important.
The way we discover and test new medicines is undergoing a massive transformation for decades the process of bringing a life saving drug to the public was a slow, paper heavy journey that required patients to live near major city hospitals. However as we move further into 2026 technology has become the heartbeat of medical progress for anyone looking to start a career in this field, the first step is often enrolling in a clinical research course in…

Bioprinting is transforming pharma and biotech by enabling realistic human tissue models, accelerating drug discovery, and supporting personalised medicine. As adoption grows, it is creating new jobs across research, engineering, data science, quality, manufacturing, and commercial strategy.
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and biotechnology industries think about drug development, regenerative medicine, and personalised healthcare. For professionals exploring future focused careers, bioprinting represents one of the most exciting intersections of biology, engineering, and digital innovation. Below, we explore what bioprinting is, why it is so important to pharma and biotech, and the key job roles it is expe…

Learn what a clinical trial protocol is, why it matters, and how it guides study design, compliance, and execution in clinical research.
A clinical trial protocol is the foundation of clinical research, detailing objectives, study design, eligibility, safety oversight, and data analysis. Its structure ensures consistency and credibility, guiding investigators while protecting participants and maintaining scientific rigor. With digital solutions, eProtocols and AI are modernizing protocols in clinical trials, making processes more adaptive and reducing inefficiencies. Introduction Every clinical trial depends on a detailed plan that outlines how the study will be run, how participants will be safeguarded, and how results will be measured. This plan, called a clini…